Matsuo et al., J. of Baceteriology, vol., 170, pp. 3847-3854, 1988. |
Douglas F. Moore, et al. Amplification of rRNA for Assessment of Treatment Response of Pulmonary Tuberculosis Patients during Antimicrobial Therapy. Journal of Clinical Microbiology, vol. 34, No. 7, pp. 1745-1749 (Jul. 1996). |
A. K. Bej, et al. Detection of viable Legionella pneumophila in Water by Polymerase Chain Reaction and Gene Probe Methods. Applied and Environmental Microbiology, vol. 57, No. 2, pp. 597-600 (Feb. 1991). |
L. E. DesJardin, et al. Alkaline Decontamination of Sputum Specimens Adversely Affects Stability of Mycobacterial mRNA. vol. 34, No. 10, pp. 2435-2439 (Oct. 1996). |
Gabrielle M. E. Van Der Vliet, et al. Assessment of Mycobacterial Viability by RNA Amplification. Antimicrobial Agents and Chemotherapy, vol. 38, No. 9, pp. 1959-1965 (Sep. 1994). |
N. Martin-Casabona, et al. Rapid Method for Testing Susceptibility of Mycobacterium tuberculosis by Using DNA Probes. Journal of Clinical Microbiology, vol. 35, No. 10, pp. 2521-2525 (Oct. 1997). |
Nainn-Tsyr Jou, et al. Single-Tube, Nested, Reverse Transcriptase PCR for Detection of Viable Mycobacterium tuberculosis. Journal of Clinical Microbiology, vol. 35, No. 5, pp. 1161-1165 (May 1997). |
Gerard A. Cangelosi, et al. Detection of Rifampin- and Ciprofloxacin-Resistant Mycobacterium tuberculosis by Using Species-Specific Assays for Precursor rRNA. Antimicrobial Agents and Chemotherapy, vol. 40, No. 8, pp. 1790-1795 (Aug. 1996). |
Diane E. Kawa, et al. Development of a Rapid Method for Determining the Susceptibility of Mycobacterium tuberculosis to Isoniazid Using the Gen-Probe DNA Hybridization System. Antimicrobial Agents and Chemotherapy, vol. 40, No. 8, pp. 1790-1795 (Aug. 1996). |
Tobin J. Hellyer, et al. Strand Displacement Amplification and the Polymerase Chain Reaction for Monitoring Response to Treatment in Patients with Pulmonary Tuberculosis. Antimicrobial Agents and Chemotherapy, vol. 173, pp. 934-941 (1996). |
Bharvin K.R. Patel et al. Determination of Mycobacterium leprae Viability by Polymerase chain Reaction Amplification of 71-kDa Heat-Shock Protein mRNA. The Journal of Infectious Diseases, vol. 168, pp. 799-800 (1993). |
Junko Miyamoto et al. New Drug Susceptibility Test for Mycobacterium tuberculosis Using the Hybridization Protection Assay. Journal of clinical Microbiology, vol. 34, No. 5 (1996). |
Nainn-Tsyr Jou, et al. Single-Tube, Nested, RT-PCR for Detection of Viable Mycobacterium tuberculosis and the Rapid Determination of Drug Susceptibility. Advances in Genetic Diagnostics for Infectious Diseases, Abstract (1995). |
L. E. DesJardin, et al. Analysis of 85B (alpha antigen) Gene Expression in Patient Sputum Using RT-PCR. 96th General Meeting of the American Society for Microbiology, Abstract U-15 (1996). |
L. E. DesJardin, et al. Treatment of Sputum with NaOH and N-acetyl cystein Adversely Affects the Stability of mRNA but not rRNA. 96th General Meeting of the American Society for Microbiology, Abstract U-25 (1996). |
L. E. DesJardin, et al. Microbial Markers as Surrogates for Response to Chemotherapy of Tuberculosis. 97th General Meeting American Society for Microbiology, Abstract U-40 (May 1997). |
L. E. DesJardin, et al. Microbial Markers as Surrogates for Response to Chemotherapy of Tuberculosis. American Thoracic Society 1997 International Conference, Abstract 117979 (May 1997). |
Tobin J. Hellyer, et al. Determination of Drug Resistance in Mycobacterium tuberculosis by Quantitative Reverse Transcriptase-PCR Using the ABI Prism 7700. ASM Conference on Tuberculosis: Past, Present, and Future, Abstract B-10 (Jul. 1997). |
L. E. DesJardin, et al. Use of competitive PCR and the ABI 7700 for Monitoring Microbial Load in Patients during Chemotherapy. ASM Conference on Tuberculosis: Past, Present, and Future, Abstract B-14 (Jul. 1997). |
L. E. DesJardin, et al. Measurement of Microbial mRNA in Sputum from Patients on Standard Tuberculosis Chemotherapy. ASM Conference on Tuberculosis: Past, Present, and Future, Abstract B-15 (Jul. 1997). |
L. E. DesJardin, et al. Microbial Markers as Surrogates for Response to Chemotherapy of Tuberculosis. Thirty-Second U.S.--Japan Cooperative Medical Science Program Tuberculosis-Leprosy Research Conference, Poster 3 (Jul. 1997). |